Hryz Bio Tech
PublicHryz Bio Tech is now publicly traded
The data on this page reflects Hryz Bio Tech's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series C
Extension
Jan 9, 2024
Total Funding Raised
$42.5M
Company Overview
Hryz Bio Tech has raised $42.5M. It was founded in 2015.
Hryz Bio Tech is a biotechnology company that develops immune cell therapy technologies for solid tumors, with product pipelines including MASCT, TCR-T, and TCR Dual Antibody.
AI Layer
Non-AI
Hryz Bio Tech Comparables
Compare Hryz Bio Tech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TCRCure Biopharma | 86% | |
| Lion TCR | 86% | |
| Zhejiang Carbiogene Therapeutics Co. Ltd. | 81% |
For institutional investors. Book with your work email.
Hryz Bio Tech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jan 9, 2024 | ||||
| Series C Extension | Aug 31, 2023 | ||||
| Series C | May 16, 2023 | ||||
| Series B Extension | Dec 6, 2022 | ||||
| Series B | Dec 28, 2020 | ||||
Series A Extension | Sep 2, 2020 |
For institutional investors. Book with your work email.
Hryz Bio Tech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Hengtai Huasheng Asset Management | Series A Extension |
| CCIC Capital | Series B Extension, Series A Extension |
| Sincere Capital | Series B |
| Zicheng Investment | Series A Extension |
| China Science & Merchants Investment Management Group | Series B Extension |
| HongShan Capital Group (HSG) | Series B Extension |
Hryz Bio Tech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.